SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-15-070952
Filing Date
2015-03-02
Accepted
2015-02-27 21:26:11
Documents
7
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d843160d10ka.htm 10-K/A 87164
  Complete submission text file 0001193125-15-070952.txt   11355953

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT hznp-20141231.xml EX-101.INS 1720232
3 XBRL TAXONOMY EXTENSION SCHEMA hznp-20141231.xsd EX-101.SCH 102816
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hznp-20141231_cal.xml EX-101.CAL 122479
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hznp-20141231_def.xml EX-101.DEF 417207
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE hznp-20141231_lab.xml EX-101.LAB 869641
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hznp-20141231_pre.xml EX-101.PRE 647445
Mailing Address ADELAIDE CHAMBERS PETER STREET DUBLIN L2 8
Business Address ADELAIDE CHAMBERS PETER STREET DUBLIN L2 8 011-353-1-649-8521
Horizon Pharma plc (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35238 | Film No.: 15661958
SIC: 2834 Pharmaceutical Preparations